Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-04-001472
Filing Date
2004-10-22
Accepted
2004-10-22 16:18:09
Documents
2
Period of Report
2004-10-20

Document Format Files

Seq Description Document Type Size
1 mcewan_ex.html 3  
1 mcewan_ex.xml 3 2682
2 p_mcewan.htm EX-24 5043
  Complete submission text file 0000950103-04-001472.txt   9649
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Issuer) CIK: 0001100682 (see all company filings)

EIN.: 061397316
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INVERESK RESEARCH GROUP, INC. 11000 WESTON PARKWAY, SUITE 100 CARY NC 27513
Business Address
MCEWAN ALASTAIR STUART (Reporting) CIK: 0001226491 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15943 | Film No.: 041092095